Billionaires Holding MDCO

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 64.5M
    Shares Outstanding

  • 2.45B
    Market Cap

News & Insights

ABOUT

MDCO

The Medicines Company provides medical solutions for patients in acute and intensive care hospitals worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous trans...

Procter & Gamble Co.'s Worst Moves in 2016

NEWS

US STOCKS-Wall St set to open flat as investors test rally

READ MORE